Our company received an expert delegation from the Ministry of Health of Iraq on July 20, 2026, who visited our factory to conduct an on-site audit and inspection
The delegation successively toured our 100,000‑class clean production workshop, professional quality control and testing center, and raw‑material traceability management exhibition hall. They conducted detailed verification of our production qualifications, ISO13485 quality management system documents, third‑party test reports for each batch of products, as well as the full‑chain supply‑chain control procedures. High recognition was granted to our standardized management covering the entire workflow from incoming raw‑material inspection to finished‑product release for delivery.
The delegation from the Iraqi Ministry of Health stated that Chinese medical products enjoy a solid global reputation for quality and cost‑performance. Following this on‑site audit, they confirmed that our production capacity and quality standards fully satisfy the procurement requirements of the Iraqi Ministry of Health, and expressed anticipation for long‑term and stable cooperation with our company.
According to our project lead, the successful completion of this factory audit marks the official launch of project implementation and delivery. Our company will strictly control product quality in compliance with cooperation terms, ensure on‑time and full‑volume delivery, support the development of Iraq’s public‑health service system, and lay a more solid foundation for high‑quality Chinese medical manufacturing to further expand into the Middle‑East market.